AFAP1 and pancreatic ductal adenocarcinoma: High AFAP1-AS1 levels were associated with malignancy, metastasis and poor prognosis of hepatocelluar carcinoma, pancreatic ductal adenocarcinoma, and gall bladder cancer [16–18].